GetTopicDetailResponse(id=002e92299f7, topicName=財(cái)報(bào), introduction=財(cái)報(bào), content=null, image=null, comments=5, allHits=1194, url=https://h5.medsci.cn/topic?id=92299, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=99175, tagList=[TagDto(tagId=99175, tagName=財(cái)報(bào))], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1721718, encodeId=d37e1e217189e, content=<a href='/topic/show?id=002e92299f7' target=_blank style='color:#2F92EE;'>#財(cái)報(bào)#</a>, objectTitle=BioNTechQ2財(cái)報(bào)亮眼，4項(xiàng)臨床試驗(yàn)針對(duì)Delta變種, objectType=article, longId=215544, objectId=3725215544f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3725215544f1, replyNumber=0, likeNumber=92, createdTime=2022-01-04, rootId=0, userName=zhu_jun9848, userId=df6833069410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3725215544f1, moduleTitle=BioNTechQ2財(cái)報(bào)亮眼，4項(xiàng)臨床試驗(yàn)針對(duì)Delta變種, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3725215544f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1721717, encodeId=16a21e21717a1, content=<a href='/topic/show?id=002e92299f7' target=_blank style='color:#2F92EE;'>#財(cái)報(bào)#</a>, objectTitle=重磅！禮來(lái)公司發(fā)布2021年第二季度財(cái)報(bào), objectType=article, longId=215372, objectId=bcc02153e2c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcc02153e2c5, replyNumber=0, likeNumber=103, createdTime=2021-12-24, rootId=0, userName=zhu_jun9848, userId=df6833069410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcc02153e2c5, moduleTitle=重磅！禮來(lái)公司發(fā)布2021年第二季度財(cái)報(bào), moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=bcc02153e2c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1721715, encodeId=6c9d1e21715e8, content=<a href='/topic/show?id=002e92299f7' target=_blank style='color:#2F92EE;'>#財(cái)報(bào)#</a>, objectTitle=諾華2019年財(cái)報(bào)：Consetyx銷售額居首，基因治療未來(lái)可期, objectType=article, longId=187082, objectId=02c618e082ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02c618e082ff, replyNumber=0, likeNumber=73, createdTime=2020-07-07, rootId=0, userName=zhu_jun9848, userId=df6833069410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02c618e082ff, moduleTitle=諾華2019年財(cái)報(bào)：Consetyx銷售額居首，基因治療未來(lái)可期, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=02c618e082ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1721716, encodeId=da691e2171668, content=<a href='/topic/show?id=002e92299f7' target=_blank style='color:#2F92EE;'>#財(cái)報(bào)#</a>, objectTitle=羅氏2019年財(cái)報(bào)：Tecentriq、Hemlibra增長(zhǎng)迅猛，中國(guó)區(qū)增速36%, objectType=article, longId=187092, objectId=a76118e0920c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a76118e0920c, replyNumber=0, likeNumber=75, createdTime=2020-02-09, rootId=0, userName=zhu_jun9848, userId=df6833069410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a76118e0920c, moduleTitle=羅氏2019年財(cái)報(bào)：Tecentriq、Hemlibra增長(zhǎng)迅猛，中國(guó)區(qū)增速36%, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a76118e0920c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1721714, encodeId=29f41e217143c, content=<a href='/topic/show?id=002e92299f7' target=_blank style='color:#2F92EE;'>#財(cái)報(bào)#</a>, objectTitle=新氧發(fā)布Q2財(cái)報(bào)：營(yíng)收2.85億，凈利潤(rùn)2930萬(wàn)元, objectType=article, longId=178418, objectId=629e1e841892, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=629e1e841892, replyNumber=0, likeNumber=62, createdTime=2020-05-09, rootId=0, userName=zhu_jun9848, userId=df6833069410, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=629e1e841892, moduleTitle=新氧發(fā)布Q2財(cái)報(bào)：營(yíng)收2.85億，凈利潤(rùn)2930萬(wàn)元, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=629e1e841892)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
